Targeting cell survival proteins for cancer cell death

MK Pandey, S Prasad, AK Tyagi, L Deb, J Huang… - Pharmaceuticals, 2016 - mdpi.com
Escaping from cell death is one of the adaptations that enable cancer cells to stave off
anticancer therapies. The key players in avoiding apoptosis are collectively known as …

Targeting the Bcl-2 family for cancer therapy

S Thomas, BA Quinn, SK Das, R Dash… - Expert opinion on …, 2013 - Taylor & Francis
Introduction: Programmed cell death is well-orchestrated process regulated by multiple pro-
apoptotic and anti-apoptotic genes, particularly those of the Bcl-2 gene family. These genes …

Endogenous and imposed determinants of apoptotic vulnerabilities in cancer

KA Sarosiek, KC Wood - Trends in Cancer, 2023 - cell.com
The intrinsic apoptosis pathway is controlled by the BCL-2 family of proteins. Although the
prosurvival members of this family can help cancer cells evade apoptosis, they may also …

Targeting the anti-apoptotic Bcl-2 family members for the treatment of cancer

B Weyhenmeyer, AC Murphy, JHM Prehn… - Experimental …, 2012 - dspace.nbuv.gov.ua
Most cells express a variety of both anti-apoptotic and pro-apoptotic Bcl-2 proteins and the
interaction within this family dictates whether a cell survives or dies. The dysregulation of the …

Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs

JB Baell, DCS Huang - Biochemical pharmacology, 2002 - Elsevier
Over the last decade the molecular mechanisms controlling programmed cell death
(apoptosis) have become clearer. It appears that many physiological and damage signals …

Resistance to HSP90 inhibition involving loss of MCL1 addiction

S Busacca, EWP Law, IR Powley, DA Proia… - Oncogene, 2016 - nature.com
Inhibition of the chaperone heat-shock protein 90 (HSP90) induces apoptosis, and it is a
promising anti-cancer strategy. The mechanisms underpinning apoptosis activation …

Escaping cell death: survival proteins in cancer

M Jäättelä - Experimental cell research, 1999 - Elsevier
Defects in apoptosis signaling pathways are common in cancer cells. Such defects may play
an important role in tumor initiation because apoptosis normally eliminates cells with …

Modulating the bcl-2 family of apoptosis suppressors for potential therapeutic benefit in cancer

GC Shore, J Viallet - ASH Education Program Book, 2005 - ashpublications.org
Members of the BCL-2 family of proteins regulate and execute many cell intrinsic apoptosis
pathways, including those arising from dysregulated expression of cellular oncogenes …

BCL-2 protein family: Attractive targets for cancer therapy

D Kaloni, ST Diepstraten, A Strasser, GL Kelly - Apoptosis, 2023 - Springer
Acquired resistance to cell death is a hallmark of cancer. The BCL-2 protein family members
play important roles in controlling apoptotic cell death. Abnormal over-expression of pro …

Rational design of therapeutics targeting the BCL-2 family: are some cancer cells primed for death but waiting for a final push?

R Khosravi-Far, E White, VDG Moore… - Programmed Cell Death in …, 2008 - Springer
A mechanism for circumventing apoptosis prevalent in many cancer cells is the
overexpression of antiapoptotic BCL-2 family members. Upregulated expression of BCL-2 …